Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Ionis Pharmaceuticals
IONS
$9.51B
| $17.8M | ﹤0.01% |
480,143
-764,381
| -61% | -$28.8M |
|
1902
CALL
Baxter International
BAX
$13.8B
| $17.7M | ﹤0.01% |
276,300
+31,400
| +13% | +$2.28M |
|
1903
PUT
Franco-Nevada
FNV
$45.2B
| $17.7M | ﹤0.01% |
134,800
+34,900
| +35% | +$5.16M |
|
1904
PUT
Ball Corp
BALL
$16.4B
| $17.7M | ﹤0.01% |
257,900
+132,400
| +105% | +$10M |
|
1905
CALL
AerCap
AER
$24B
| $17.7M | ﹤0.01% |
432,400
-149,400
| -26% | -$6.92M |
|
1906
Dycom Industries
DY
$12.6B
| $17.7M | ﹤0.01% |
190,126
-47,593
| -20% | -$4.24M |
|
1907
CALL
Steel Dynamics
STLD
$36.7B
| $17.7M | ﹤0.01% |
267,300
+34,500
| +15% | +$2.76M |
|
1908
CALL
PennyMac Financial
PFSI
$4.05B
| $17.7M | ﹤0.01% |
404,500
+193,400
| +92% | +$9.13M |
|
1909
Unum
UNM
$14.8B
| $17.7M | ﹤0.01% |
519,743
-433,815
| -45% | -$14.7M |
|
|
HCNE
1910
DELISTED
Jaws Hurricane Acquisition Corp. Class A Common Stock
HCNE
| $17.7M | ﹤0.01% |
1,814,427
+2
| +0% | +$19 |
|
1911
CALL
Weyerhaeuser
WY
$17.7B
| $17.7M | ﹤0.01% |
533,500
+227,200
| +74% | +$8.66M |
|
1912
Moody's
MCO
$84B
| $17.7M | ﹤0.01% |
64,962
+50,981
| +365% | +$15.3M |
|
1913
Loews
L
$23.1B
| $17.6M | ﹤0.01% |
297,624
+225,542
| +313% | +$14.2M |
|
1914
Warrior Met Coal
HCC
$5.19B
| $17.6M | ﹤0.01% |
576,150
-114,906
| -17% | -$3.98M |
|
1915
PUT
Aon
AON
$75.5B
| $17.6M | ﹤0.01% |
65,300
+37,200
| +132% | +$10.7M |
|
1916
PUT
Invesco CurrencyShares Canadian Dollar Trust
FXC
$73.9M
| $17.6M | ﹤0.01% |
231,800
+222,500
| +2,392% | +$17M |
|
|
FISV
1917
Fiserv Inc
FISV
$28.9B
| $17.5M | ﹤0.01% |
197,193
+151,031
| +327% | +$14.6M |
|
1918
Nutanix
NTNX
$18B
| $17.5M | ﹤0.01% |
1,196,966
-398,842
| -25% | -$8.31M |
|
1919
Bread Financial
BFH
$4.58B
| $17.5M | ﹤0.01% |
472,326
+338,567
| +253% | +$17.3M |
|
1920
CALL
Synchrony
SYF
$26.4B
| $17.5M | ﹤0.01% |
633,700
+298,900
| +89% | +$10.4M |
|
1921
PUT
AngloGold Ashanti
AU
$48.7B
| $17.5M | ﹤0.01% |
1,183,200
-227,700
| -16% | -$4.32M |
|
1922
Tyson Foods
TSN
$20.5B
| $17.5M | ﹤0.01% |
203,291
+89,750
| +79% | +$8.04M |
|
|
HRT
1923
DELISTED
HireRight Holdings Corporation
HRT
| $17.5M | ﹤0.01% |
1,229,065
-479
| -0% | -$7.47K |
|
1924
WEX
WEX
$6.54B
| $17.4M | ﹤0.01% |
112,170
+53,609
| +92% | +$8.78M |
|
1925
CALL
Check Point Software Technologies
CHKP
$13.4B
| $17.4M | ﹤0.01% |
143,200
+39,000
| +37% | +$5.01M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.